Literature DB >> 6662211

Polyamines in normal and cataractous human lenses: evidence for post-translational modification.

L T Kremzner, D Roy, A Spector.   

Abstract

The polyamine composition of normal and cataractous human lenses has been studied. Polyamines (putrescine, spermidine and spermine) have been shown to occur in the unbound form in the acid-soluble fraction and in the bound form in the acid-insoluble fraction of the lens. It has also been shown that only putrescine occurs in both conjugated and non-conjugated states in the lens, while putrescine as well as spermidine occur in both forms in the aqueous fluid. Estimation of the polyamine content in cataractous lenses indicates elevated levels of both bound and unbound polyamines in these lenses in comparison to the normal lenses. Evidence is presented which indicates an increase in the level of polyamines covalently bound to protein, in a gamma-glutamyl linkage, in the cataractous lens.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6662211     DOI: 10.1016/0014-4835(83)90139-2

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  4 in total

Review 1.  Phase I and phase II ocular metabolic activities and the role of metabolism in ophthalmic prodrug and codrug design and delivery.

Authors:  Abeer M Al-Ghananeem; Peter A Crooks
Journal:  Molecules       Date:  2007-03-08       Impact factor: 4.411

2.  Spermidine delays eye lens opacification in vitro by suppressing transglutaminase-catalyzed crystallin cross-linking.

Authors:  Alessandro Lentini; Claudio Tabolacci; Palma Mattioli; Bruno Provenzano; Simone Beninati
Journal:  Protein J       Date:  2011-02       Impact factor: 2.371

3.  Nondisulfide polymerization of gamma- and beta-crystallins in the human lens.

Authors:  D Roy; J Dillon; E Wada; W Chaney; A Spector
Journal:  Proc Natl Acad Sci U S A       Date:  1984-05       Impact factor: 11.205

Review 4.  Research Progress and Potential Applications of Spermidine in Ocular Diseases.

Authors:  Wentao Han; Haoyu Li; Baihua Chen
Journal:  Pharmaceutics       Date:  2022-07-19       Impact factor: 6.525

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.